BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Afyon M. Letter: nucleos(t)ide analogues are good, but not sufficient for hepatitis B virus clearance. Aliment Pharmacol Ther 2016;43:654-5. [DOI: 10.1111/apt.13502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Liaw YF. Letter: nucleos(t)ide analogues are good, but not sufficient for hepatitis B virus clearance--author's reply. Aliment Pharmacol Ther 2016;43:655-6. [PMID: 26843345 DOI: 10.1111/apt.13510] [Reference Citation Analysis]
2 Marcellin P, Ahn SH, Chuang W, Hui AJ, Tabak F, Mehta R, Petersen J, Lee C, Ma X, Caruntu FA, Tak WY, Elkhashab M, Lin L, Wu G, Martins EB, Charuworn P, Yee LJ, Lim SG, Foster GR, Fung S, Morano L, Samuel D, Agarwal K, Idilman R, Strasser SI, Buti M, Gaeta GB, Papatheodoridis G, Flisiak R, Chan HLY. Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B. Aliment Pharmacol Ther 2016;44:957-66. [DOI: 10.1111/apt.13779] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]